drugset / Trial / NCT01674855
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to determine whether once-per-cycle DA-3031(PEG-G-CSF) is not inferior to daily G-CSF in chemotherapy-induced neutropenia.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-02
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | G-CSF | Unknown | 100 ug/m2 | — |
| Subject | Pegfilgrastim | Protein / enzyme biologic | 6 mg | — |